← Leaderboards
Maria Trojanowska
Boston University Medical Campus
$16,742,564
Attributed
$18,030,234
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,030,234 · 10
By mechanism
R01$13,479,082 · 4
P50$2,684,019 · 2
P01$973,363 · 1
R56$409,583 · 1
R21$292,000 · 1
P60$192,187 · 1
Top collaborators
- Elena Goncharova4 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Matthew D Layne$5,684,227
- Katya Ravid$16,580,337
- David J Waxman$23,862,644
- Elena Goncharova$9,715,004
- Robert A Lafyatis$10,905,922
Others in their field
Top investigators on “Scleroderma”
- Eugene W. St Clair · Duke University$24,182,181
- John Varga · University Of Illinois At Chicago$15,372,802
- Roger A Johns · Johns Hopkins University$12,479,815
- Carol A Feghali-Bostwick · University Of Pittsburgh At Pittsburgh$12,032,767
- Judith A James · Oklahoma Medical Research Foundation$11,331,322
- Robert M Elashoff · John Wayne Cancer Institute$10,394,671
Research focus
SclerodermaPathologicMolecularFibroblastsPathway InteractionsFibrosisBaseBlood VesselsSignal TransductionEndothelial CellsCollagenHomeostasisPathogenesisSkinSignal PathwayGenesResponseSystemic SclerodermaTranscription FactorPlayImmuneMediator Of Activation ProteinComplexFunctional Disorder
Grant awards (58)
Lymphatic ERG signaling in scleroderma fibrosis$537,014
R01 · FY2025 · AR · contact PI
Lymphatic ERG signaling in scleroderma fibrosis$591,238
R01 · FY2024 · AR · contact PI
GATA-6 in pulmonary arterial hypertension$632,908
R01 · FY2023 · HL · contact PI
Lymphatic ERG signaling in scleroderma fibrosis$603,465
R01 · FY2023 · AR · contact PI
GATA-6 in pulmonary arterial hypertension$637,597
R01 · FY2022 · HL · contact PI
Lymphatic ERG signaling in scleroderma fibrosis$621,218
R01 · FY2022 · AR · contact PI
GATA-6 in pulmonary arterial hypertension$641,192
R01 · FY2021 · HL · contact PI
Project 2: Scleroderma-Associated Pulmonary Arterial Hypertension: The Role of the Oxidant State$231,696
P50 · FY2021 · AR · contact PI
GATA-6 in pulmonary arterial hypertension$663,643
R01 · FY2020 · HL · contact PI
Project 2: Scleroderma-Associated Pulmonary Arterial Hypertension: The Role of the Oxidant State$260,785
P50 · FY2020 · AR · contact PI
Project 2: Scleroderma-Associated Pulmonary Arterial Hypertension: The Role of the Oxidant State$231,697
P50 · FY2019 · AR · contact PI
The molecular mechanism of vasculopathy and fibrosis in scleroderma$360,140
R01 · FY2018 · AR · contact PI
Project 2: Scleroderma-Associated Pulmonary Arterial Hypertension: The Role of the Oxidant State$222,890
P50 · FY2018 · AR · contact PI
The molecular mechanism of vasculopathy and fibrosis in scleroderma$360,140
R01 · FY2017 · AR · contact PI
Project 2: Scleroderma-Associated Pulmonary Arterial Hypertension: The Role of the Oxidant State$187,046
P50 · FY2017 · AR · contact PI
The molecular mechanism of vasculopathy and fibrosis in scleroderma$360,140
R01 · FY2016 · AR · contact PI
TGF-beta receptor/Endoglin signaling and the origin of scleroderma fibroblast$409,583
R56 · FY2015 · AR · contact PI
The molecular mechanism of vasculopathy and fibrosis in scleroderma$360,140
R01 · FY2015 · AR · contact PI
The Role of ER Stress in Systemic Scleroderma$302,591
P50 · FY2015 · AR · contact PI
The molecular mechanism of vasculopathy and fibrosis in scleroderma$360,140
R01 · FY2014 · AR · contact PI
The Role of ER Stress in Systemic Scleroderma$304,628
P50 · FY2014 · AR · contact PI
The Role of ER Stress in Systemic Scleroderma$299,813
P50 · FY2013 · AR · contact PI
TGF-beta receptor signaling in scleroderma$339,768
R01 · FY2012 · AR · contact PI
The molecular mechanisms of fibrosis$339,768
R01 · FY2012 · AR · contact PI
The Role of ER Stress in Systemic Scleroderma$319,198
P50 · FY2012 · AR · contact PI
TGF-beta receptor signaling in scleroderma$339,768
R01 · FY2011 · AR · contact PI
The molecular mechanisms of fibrosis$339,768
R01 · FY2011 · AR · contact PI
The Role of ER Stress in Systemic Scleroderma$323,675
P50 · FY2011 · AR · contact PI
TGF-beta receptor signaling in scleroderma$353,925
R01 · FY2010 · AR · contact PI
The molecular mechanisms of fibrosis$353,925
R01 · FY2010 · AR · contact PI
TGF-beta receptor signaling in scleroderma$244,850
R01 · FY2009 · AR · contact PI
ETS1 AND FLI1 IN STROMAL ACTIVATION IN BREAST CANCER$234,164
P01 · FY2009 · CA · contact PI
The molecular mechanisms of fibrosis$181,425
R01 · FY2009 · AR · contact PI
The molecular mechanisms of fibrosis$139,775
R01 · FY2009 · AR · contact PI
TGF-beta receptor signaling in scleroderma$79,650
R01 · FY2009 · AR · contact PI
TGF-beta receptor signaling in scleroderma$324,500
R01 · FY2008 · AR · contact PI
The molecular mechanisms of fibrosis$321,200
R01 · FY2008 · AR · contact PI
ETS1 AND FLI1 IN STROMAL ACTIVATION IN BREAST CANCER$227,315
P01 · FY2008 · CA · contact PI
Fibrosis: molecular basis of fibroblast activation$247,797
R01 · FY2007 · AR · contact PI
ETS1 AND FLI1 IN STROMAL ACTIVATION IN BREAST CANCER$222,198
P01 · FY2007 · CA · contact PI
Sphingosine Kinase in Systemic Sclerosis (Scleroderma)$192,187
P60 · FY2007 · AR · contact PI
Fibrosis: molecular basis of fibroblast activation$255,198
R01 · FY2006 · AR · contact PI
TGF-beta receptor signaling in scleroderma$246,644
R01 · FY2006 · AR · contact PI
ETS1 AND FLI1 IN STROMAL ACTIVATION IN BREAST CANCER$144,741
P01 · FY2006 · CA · contact PI
Fibrosis: molecular basis of fibroblast activation$283,240
R01 · FY2005 · AR
TGF-beta receptor signaling in scleroderma$252,580
R01 · FY2005 · AR
ETS1 AND FLI1 IN STROMAL ACTIVATION IN BREAST CANCER$144,945
P01 · FY2005 · CA
Fibrosis: molecular basis of fibroblast activation$283,240
R01 · FY2004 · AR
TGF-beta receptor signaling in scleroderma$274,480
R01 · FY2004 · AR
Mechanism of endothelial cell damage in scleroderma$146,000
R21 · FY2004 · AR
Fibrosis: molecular basis of fibroblast activation$283,240
R01 · FY2003 · AR
TGF-beta receptor signaling in scleroderma$274,480
R01 · FY2003 · AR
Mechanism of endothelial cell damage in scleroderma$146,000
R21 · FY2003 · AR
TGF-beta receptor signaling in scleroderma$274,480
R01 · FY2002 · AR
FIBROSIS--MOLECULAR BASIS FOR FIBROBLAST ACTIVATION$197,202
R01 · FY2001 · AR
TGF BETA RECEPTOR SIGNALING IN SCLERODERMA$166,280
R01 · FY2001 · AR
FIBROSIS--MOLECULAR BASIS FOR FIBROBLAST ACTIVATION$191,458
R01 · FY2000 · AR
TGF BETA RECEPTOR SIGNALING IN SCLERODERMA$161,466
R01 · FY2000 · AR